Effects on postural oscillation and memory functions of a single dose of zolpidem 5 mg, zopiclone 3.75 mg and lormetazepam 1 mg in elderly healthy subjects. A randomized, cross-over, double-blind study versus placebo

In elderly patients, both falls and impaired memory are considerable medical problems. Hypnotics, which are frequently administered to this patient group for the treatment of insomnia, should ideally not impair equilibrium or memory functions. This double-blind, randomised, four-way, cross-over stud...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of clinical pharmacology 2003-07, Vol.59 (3), p.179-188
Hauptverfasser: ALLAIN, Hervé, BENTUE-FERRER, Danièle, TARRAL, Antoine, GANDON, Jean-Marc
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 188
container_issue 3
container_start_page 179
container_title European journal of clinical pharmacology
container_volume 59
creator ALLAIN, Hervé
BENTUE-FERRER, Danièle
TARRAL, Antoine
GANDON, Jean-Marc
description In elderly patients, both falls and impaired memory are considerable medical problems. Hypnotics, which are frequently administered to this patient group for the treatment of insomnia, should ideally not impair equilibrium or memory functions. This double-blind, randomised, four-way, cross-over study investigated the effects of frequently prescribed hypnotics from different classes on postural oscillation and memory under real life conditions. Zolpidem 5 mg, zopiclone 3.75 mg, lormetazepam 1 mg (i.e. usual starting doses in elderly) or placebo were administered at night to 48 healthy elderly volunteers aged 65 years or more. The study included four treatment periods separated by wash-out periods of at least 1 week. Psychomotor tests up to 9 h or 10 h after drug intake included, for attention and body sway, clinical stabilometric platform (CSP) tests, simple reaction time (SRT), and the critical tracking test (CTT); for memory, the learning memory tasks (LMT) and the Sternberg memory scanning test (mean reaction time [MRT] and percentage of correct answers) were used. For subjective sleep evaluation the Leeds sleep evaluation questionnaire (LSEQ) and for sedation a visual analogue scale (VAS) were used. For safety evaluations, adverse events (AEs) were recorded. The results demonstrate that compared with placebo, the active drugs increased body sway (area eyes open and closed in the CSP); however, this effect disappeared after 5 h with zolpidem, while it disappeared only after 8 h with lormetazepam and zopiclone. All three drugs did not affect attention assessed by the SRT and CTT. Concerning memory, Sternberg MRT at 9 h was not significantly different up to 5 digits for all groups in comparison with placebo, while for 6 digits it was significantly increased with lormetazepam and zopiclone. In the LMT, an impairment of performance was observed with lormetazepam relative to both zolpidem and placebo. The safest compared drug with regard to body sway was zolpidem, because of its short-lasting effect. In addition, zolpidem did not show any significant effect on memory functions, in the present dose comparison.
doi_str_mv 10.1007/s00228-003-0591-5
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_214478295</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>815858391</sourcerecordid><originalsourceid>FETCH-LOGICAL-c354t-771f14b2d9881953e23f585684d0df843460d490d26c60b1ba9f085fd2995f4b3</originalsourceid><addsrcrecordid>eNpFkc1u1DAUhS0EosPAA7BBFhK78XD9l8TLqiq0UiU2sI4c_7QZOXGwE6SZJ-Vx6nRG6sryd88999oHoc8U9hSg_p4BGGsIACcgFSXyDdpQwRmhIOhbtCkFSipVwxX6kPMBgEoF_D26oqyWlaSwQf9vvXdmzjiOeIp5XpIOOGbTh6DnvkA9Wjy4IaYj9stoVlbEHmuc-_ExOGxjdis4xTD11g1Y4uFxV65Tb0IcHeb7ekUvTiGmwc365CY9YLrSfsQuWJfCET85HeanI85Ld1h32uNrnEpXHPqTsztsUsyZxH8u7crUpQuOdKEvrmVte8SF5yXjKWjjuvgRvfM6ZPfpcm7Rnx-3v2_uyMOvn_c31w_EcClmUtfUU9Exq5qGKskd4142smqEBesbwUUFViiwrDIVdLTTykMjvWVKSS86vkVfz75Tin8Xl-f2EJc0lpEto0LUDSuuW0TPopcnJOfbKfWDTseWQrtG2Z6jbEti7Rplu_Z8uRgv3eDsa8cluyL4dhHobHTw5atMn191EmitZMWfAXwfqKQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>214478295</pqid></control><display><type>article</type><title>Effects on postural oscillation and memory functions of a single dose of zolpidem 5 mg, zopiclone 3.75 mg and lormetazepam 1 mg in elderly healthy subjects. A randomized, cross-over, double-blind study versus placebo</title><source>MEDLINE</source><source>SpringerLink</source><creator>ALLAIN, Hervé ; BENTUE-FERRER, Danièle ; TARRAL, Antoine ; GANDON, Jean-Marc</creator><creatorcontrib>ALLAIN, Hervé ; BENTUE-FERRER, Danièle ; TARRAL, Antoine ; GANDON, Jean-Marc</creatorcontrib><description>In elderly patients, both falls and impaired memory are considerable medical problems. Hypnotics, which are frequently administered to this patient group for the treatment of insomnia, should ideally not impair equilibrium or memory functions. This double-blind, randomised, four-way, cross-over study investigated the effects of frequently prescribed hypnotics from different classes on postural oscillation and memory under real life conditions. Zolpidem 5 mg, zopiclone 3.75 mg, lormetazepam 1 mg (i.e. usual starting doses in elderly) or placebo were administered at night to 48 healthy elderly volunteers aged 65 years or more. The study included four treatment periods separated by wash-out periods of at least 1 week. Psychomotor tests up to 9 h or 10 h after drug intake included, for attention and body sway, clinical stabilometric platform (CSP) tests, simple reaction time (SRT), and the critical tracking test (CTT); for memory, the learning memory tasks (LMT) and the Sternberg memory scanning test (mean reaction time [MRT] and percentage of correct answers) were used. For subjective sleep evaluation the Leeds sleep evaluation questionnaire (LSEQ) and for sedation a visual analogue scale (VAS) were used. For safety evaluations, adverse events (AEs) were recorded. The results demonstrate that compared with placebo, the active drugs increased body sway (area eyes open and closed in the CSP); however, this effect disappeared after 5 h with zolpidem, while it disappeared only after 8 h with lormetazepam and zopiclone. All three drugs did not affect attention assessed by the SRT and CTT. Concerning memory, Sternberg MRT at 9 h was not significantly different up to 5 digits for all groups in comparison with placebo, while for 6 digits it was significantly increased with lormetazepam and zopiclone. In the LMT, an impairment of performance was observed with lormetazepam relative to both zolpidem and placebo. The safest compared drug with regard to body sway was zolpidem, because of its short-lasting effect. In addition, zolpidem did not show any significant effect on memory functions, in the present dose comparison.</description><identifier>ISSN: 0031-6970</identifier><identifier>EISSN: 1432-1041</identifier><identifier>DOI: 10.1007/s00228-003-0591-5</identifier><identifier>PMID: 12756510</identifier><language>eng</language><publisher>Heidelberg: Springer</publisher><subject>Aged ; Attention - drug effects ; Azabicyclo Compounds ; Biological and medical sciences ; Cross-Over Studies ; Double-Blind Method ; Female ; Humans ; Hypnotics and Sedatives - administration &amp; dosage ; Hypnotics and Sedatives - adverse effects ; Hypnotics. Sedatives ; Lorazepam - administration &amp; dosage ; Lorazepam - adverse effects ; Lorazepam - analogs &amp; derivatives ; Male ; Medical sciences ; Memory - drug effects ; Neuropharmacology ; Pharmacology. Drug treatments ; Piperazines - administration &amp; dosage ; Piperazines - adverse effects ; Placebos ; Postural Balance - drug effects ; Psychology. Psychoanalysis. Psychiatry ; Psychomotor Performance - drug effects ; Psychopharmacology ; Pyridines - administration &amp; dosage ; Pyridines - adverse effects ; Reaction Time - drug effects ; Sensation Disorders - chemically induced ; Sleep - drug effects</subject><ispartof>European journal of clinical pharmacology, 2003-07, Vol.59 (3), p.179-188</ispartof><rights>2004 INIST-CNRS</rights><rights>Springer-Verlag 2003</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c354t-771f14b2d9881953e23f585684d0df843460d490d26c60b1ba9f085fd2995f4b3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15017956$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12756510$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>ALLAIN, Hervé</creatorcontrib><creatorcontrib>BENTUE-FERRER, Danièle</creatorcontrib><creatorcontrib>TARRAL, Antoine</creatorcontrib><creatorcontrib>GANDON, Jean-Marc</creatorcontrib><title>Effects on postural oscillation and memory functions of a single dose of zolpidem 5 mg, zopiclone 3.75 mg and lormetazepam 1 mg in elderly healthy subjects. A randomized, cross-over, double-blind study versus placebo</title><title>European journal of clinical pharmacology</title><addtitle>Eur J Clin Pharmacol</addtitle><description>In elderly patients, both falls and impaired memory are considerable medical problems. Hypnotics, which are frequently administered to this patient group for the treatment of insomnia, should ideally not impair equilibrium or memory functions. This double-blind, randomised, four-way, cross-over study investigated the effects of frequently prescribed hypnotics from different classes on postural oscillation and memory under real life conditions. Zolpidem 5 mg, zopiclone 3.75 mg, lormetazepam 1 mg (i.e. usual starting doses in elderly) or placebo were administered at night to 48 healthy elderly volunteers aged 65 years or more. The study included four treatment periods separated by wash-out periods of at least 1 week. Psychomotor tests up to 9 h or 10 h after drug intake included, for attention and body sway, clinical stabilometric platform (CSP) tests, simple reaction time (SRT), and the critical tracking test (CTT); for memory, the learning memory tasks (LMT) and the Sternberg memory scanning test (mean reaction time [MRT] and percentage of correct answers) were used. For subjective sleep evaluation the Leeds sleep evaluation questionnaire (LSEQ) and for sedation a visual analogue scale (VAS) were used. For safety evaluations, adverse events (AEs) were recorded. The results demonstrate that compared with placebo, the active drugs increased body sway (area eyes open and closed in the CSP); however, this effect disappeared after 5 h with zolpidem, while it disappeared only after 8 h with lormetazepam and zopiclone. All three drugs did not affect attention assessed by the SRT and CTT. Concerning memory, Sternberg MRT at 9 h was not significantly different up to 5 digits for all groups in comparison with placebo, while for 6 digits it was significantly increased with lormetazepam and zopiclone. In the LMT, an impairment of performance was observed with lormetazepam relative to both zolpidem and placebo. The safest compared drug with regard to body sway was zolpidem, because of its short-lasting effect. In addition, zolpidem did not show any significant effect on memory functions, in the present dose comparison.</description><subject>Aged</subject><subject>Attention - drug effects</subject><subject>Azabicyclo Compounds</subject><subject>Biological and medical sciences</subject><subject>Cross-Over Studies</subject><subject>Double-Blind Method</subject><subject>Female</subject><subject>Humans</subject><subject>Hypnotics and Sedatives - administration &amp; dosage</subject><subject>Hypnotics and Sedatives - adverse effects</subject><subject>Hypnotics. Sedatives</subject><subject>Lorazepam - administration &amp; dosage</subject><subject>Lorazepam - adverse effects</subject><subject>Lorazepam - analogs &amp; derivatives</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Memory - drug effects</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Piperazines - administration &amp; dosage</subject><subject>Piperazines - adverse effects</subject><subject>Placebos</subject><subject>Postural Balance - drug effects</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychomotor Performance - drug effects</subject><subject>Psychopharmacology</subject><subject>Pyridines - administration &amp; dosage</subject><subject>Pyridines - adverse effects</subject><subject>Reaction Time - drug effects</subject><subject>Sensation Disorders - chemically induced</subject><subject>Sleep - drug effects</subject><issn>0031-6970</issn><issn>1432-1041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpFkc1u1DAUhS0EosPAA7BBFhK78XD9l8TLqiq0UiU2sI4c_7QZOXGwE6SZJ-Vx6nRG6sryd88999oHoc8U9hSg_p4BGGsIACcgFSXyDdpQwRmhIOhbtCkFSipVwxX6kPMBgEoF_D26oqyWlaSwQf9vvXdmzjiOeIp5XpIOOGbTh6DnvkA9Wjy4IaYj9stoVlbEHmuc-_ExOGxjdis4xTD11g1Y4uFxV65Tb0IcHeb7ekUvTiGmwc365CY9YLrSfsQuWJfCET85HeanI85Ld1h32uNrnEpXHPqTsztsUsyZxH8u7crUpQuOdKEvrmVte8SF5yXjKWjjuvgRvfM6ZPfpcm7Rnx-3v2_uyMOvn_c31w_EcClmUtfUU9Exq5qGKskd4142smqEBesbwUUFViiwrDIVdLTTykMjvWVKSS86vkVfz75Tin8Xl-f2EJc0lpEto0LUDSuuW0TPopcnJOfbKfWDTseWQrtG2Z6jbEti7Rplu_Z8uRgv3eDsa8cluyL4dhHobHTw5atMn191EmitZMWfAXwfqKQ</recordid><startdate>20030701</startdate><enddate>20030701</enddate><creator>ALLAIN, Hervé</creator><creator>BENTUE-FERRER, Danièle</creator><creator>TARRAL, Antoine</creator><creator>GANDON, Jean-Marc</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20030701</creationdate><title>Effects on postural oscillation and memory functions of a single dose of zolpidem 5 mg, zopiclone 3.75 mg and lormetazepam 1 mg in elderly healthy subjects. A randomized, cross-over, double-blind study versus placebo</title><author>ALLAIN, Hervé ; BENTUE-FERRER, Danièle ; TARRAL, Antoine ; GANDON, Jean-Marc</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c354t-771f14b2d9881953e23f585684d0df843460d490d26c60b1ba9f085fd2995f4b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Aged</topic><topic>Attention - drug effects</topic><topic>Azabicyclo Compounds</topic><topic>Biological and medical sciences</topic><topic>Cross-Over Studies</topic><topic>Double-Blind Method</topic><topic>Female</topic><topic>Humans</topic><topic>Hypnotics and Sedatives - administration &amp; dosage</topic><topic>Hypnotics and Sedatives - adverse effects</topic><topic>Hypnotics. Sedatives</topic><topic>Lorazepam - administration &amp; dosage</topic><topic>Lorazepam - adverse effects</topic><topic>Lorazepam - analogs &amp; derivatives</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Memory - drug effects</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Piperazines - administration &amp; dosage</topic><topic>Piperazines - adverse effects</topic><topic>Placebos</topic><topic>Postural Balance - drug effects</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychomotor Performance - drug effects</topic><topic>Psychopharmacology</topic><topic>Pyridines - administration &amp; dosage</topic><topic>Pyridines - adverse effects</topic><topic>Reaction Time - drug effects</topic><topic>Sensation Disorders - chemically induced</topic><topic>Sleep - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ALLAIN, Hervé</creatorcontrib><creatorcontrib>BENTUE-FERRER, Danièle</creatorcontrib><creatorcontrib>TARRAL, Antoine</creatorcontrib><creatorcontrib>GANDON, Jean-Marc</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing &amp; Allied Health Source</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>European journal of clinical pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ALLAIN, Hervé</au><au>BENTUE-FERRER, Danièle</au><au>TARRAL, Antoine</au><au>GANDON, Jean-Marc</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects on postural oscillation and memory functions of a single dose of zolpidem 5 mg, zopiclone 3.75 mg and lormetazepam 1 mg in elderly healthy subjects. A randomized, cross-over, double-blind study versus placebo</atitle><jtitle>European journal of clinical pharmacology</jtitle><addtitle>Eur J Clin Pharmacol</addtitle><date>2003-07-01</date><risdate>2003</risdate><volume>59</volume><issue>3</issue><spage>179</spage><epage>188</epage><pages>179-188</pages><issn>0031-6970</issn><eissn>1432-1041</eissn><abstract>In elderly patients, both falls and impaired memory are considerable medical problems. Hypnotics, which are frequently administered to this patient group for the treatment of insomnia, should ideally not impair equilibrium or memory functions. This double-blind, randomised, four-way, cross-over study investigated the effects of frequently prescribed hypnotics from different classes on postural oscillation and memory under real life conditions. Zolpidem 5 mg, zopiclone 3.75 mg, lormetazepam 1 mg (i.e. usual starting doses in elderly) or placebo were administered at night to 48 healthy elderly volunteers aged 65 years or more. The study included four treatment periods separated by wash-out periods of at least 1 week. Psychomotor tests up to 9 h or 10 h after drug intake included, for attention and body sway, clinical stabilometric platform (CSP) tests, simple reaction time (SRT), and the critical tracking test (CTT); for memory, the learning memory tasks (LMT) and the Sternberg memory scanning test (mean reaction time [MRT] and percentage of correct answers) were used. For subjective sleep evaluation the Leeds sleep evaluation questionnaire (LSEQ) and for sedation a visual analogue scale (VAS) were used. For safety evaluations, adverse events (AEs) were recorded. The results demonstrate that compared with placebo, the active drugs increased body sway (area eyes open and closed in the CSP); however, this effect disappeared after 5 h with zolpidem, while it disappeared only after 8 h with lormetazepam and zopiclone. All three drugs did not affect attention assessed by the SRT and CTT. Concerning memory, Sternberg MRT at 9 h was not significantly different up to 5 digits for all groups in comparison with placebo, while for 6 digits it was significantly increased with lormetazepam and zopiclone. In the LMT, an impairment of performance was observed with lormetazepam relative to both zolpidem and placebo. The safest compared drug with regard to body sway was zolpidem, because of its short-lasting effect. In addition, zolpidem did not show any significant effect on memory functions, in the present dose comparison.</abstract><cop>Heidelberg</cop><cop>Berlin</cop><pub>Springer</pub><pmid>12756510</pmid><doi>10.1007/s00228-003-0591-5</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0031-6970
ispartof European journal of clinical pharmacology, 2003-07, Vol.59 (3), p.179-188
issn 0031-6970
1432-1041
language eng
recordid cdi_proquest_journals_214478295
source MEDLINE; SpringerLink
subjects Aged
Attention - drug effects
Azabicyclo Compounds
Biological and medical sciences
Cross-Over Studies
Double-Blind Method
Female
Humans
Hypnotics and Sedatives - administration & dosage
Hypnotics and Sedatives - adverse effects
Hypnotics. Sedatives
Lorazepam - administration & dosage
Lorazepam - adverse effects
Lorazepam - analogs & derivatives
Male
Medical sciences
Memory - drug effects
Neuropharmacology
Pharmacology. Drug treatments
Piperazines - administration & dosage
Piperazines - adverse effects
Placebos
Postural Balance - drug effects
Psychology. Psychoanalysis. Psychiatry
Psychomotor Performance - drug effects
Psychopharmacology
Pyridines - administration & dosage
Pyridines - adverse effects
Reaction Time - drug effects
Sensation Disorders - chemically induced
Sleep - drug effects
title Effects on postural oscillation and memory functions of a single dose of zolpidem 5 mg, zopiclone 3.75 mg and lormetazepam 1 mg in elderly healthy subjects. A randomized, cross-over, double-blind study versus placebo
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T17%3A56%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20on%20postural%20oscillation%20and%20memory%20functions%20of%20a%20single%20dose%20of%20zolpidem%205%20mg,%20zopiclone%203.75%20mg%20and%20lormetazepam%201%20mg%20in%20elderly%20healthy%20subjects.%20A%20randomized,%20cross-over,%20double-blind%20study%20versus%20placebo&rft.jtitle=European%20journal%20of%20clinical%20pharmacology&rft.au=ALLAIN,%20Herv%C3%A9&rft.date=2003-07-01&rft.volume=59&rft.issue=3&rft.spage=179&rft.epage=188&rft.pages=179-188&rft.issn=0031-6970&rft.eissn=1432-1041&rft_id=info:doi/10.1007/s00228-003-0591-5&rft_dat=%3Cproquest_cross%3E815858391%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=214478295&rft_id=info:pmid/12756510&rfr_iscdi=true